(Q32034877)

5 July 2017

1 reference

title

Cerebral changes in hepatic encephalopathy (English)

1 reference

5 July 2017

hepatic encephalopathy

1 reference

Watanabe A

1

1 reference

5 July 2017

1 July 1998

1 reference

Journal of Gastroenterology and Hepatology

5 July 2017

1 reference

5 July 2017

13

1 reference

5 July 2017

7

1 reference

5 July 2017

752-760

1 reference

The auditory P300 event-related potential: an objective marker of the encephalopathy of chronic liver disease

5 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00728.X

Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00728.X

Neuropsychological deficits and morphological MRI brain scan abnormalities in apparently healthy non-encephalopathic patients with cirrhosis. A controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00728.X

Measurement of the expiratory ammonia concentration and its clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00728.X

Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00728.X

Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00728.X

Subclinical hepatic encephalopathy: the diagnostic value of evoked potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00728.X

Brain mapping analysis in patients with hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00728.X

Mechanism of the excessive sedative response of cirrhotics to benzodiazepines: model experiments with triazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00728.X

Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00728.X

Manganese and chronic hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00728.X

A quantitative evaluation of magnetic resonance image signal changes of the brain in chronic hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00728.X

Echo-planar imaging: magnetic resonance imaging in a fraction of a second

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00728.X

Noninvasive measurements of regional cerebral blood flow using technetium-99m hexamethylpropylene amine oxime.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00728.X

Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00728.X

Blood-brain neutral amino acid transport activity is increased after portacaval anastomosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00728.X

Ammonia detoxification by accelerated oxidation of branched chain amino acids in brains of acute hepatic failure rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00728.X

Amino acid, ammonia and neurotransmitter concentrations in hepatic encephalopathy: serial analysis in plasma and cerebrospinal fluid during treatment with an adapted amino acid solution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00728.X

Neurochemical effects of choline supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00728.X

Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00728.X

10.1111/J.1440-1746.1998.TB00728.X

21 January 2018

Identifiers

DOI

1 reference

5 July 2017

1 reference

PubMed ID

9715431